AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
Healthcare
FTSE 100: AstraZeneca Secures EU Approval – What It Means for LSE:AZN Stock?
July 08, 2025 04:51 AM AEST| By Team Kalkine MediaHighlights,AstraZeneca received European Commission approval for a new cancer treatment.,The approval supports the company’s oncology product line in the European market.,AstraZeneca focuses on expanding treatment options across its pharmaceutical po...
How Is (LSE:AZN) AstraZeneca Advancing Bladder Cancer Therapy Within the FTSE 350 Framework?
July 04, 2025 09:00 AM AEST| By Team Kalkine MediaHighlights,AstraZeneca gains European regulatory approval for Imfinzi in muscle-invasive bladder cancer.,The treatment includes perioperative administration, combining pre- and post-surgical delivery.,The development underlines AstraZeneca’s role wit...
How AstraZeneca (LSE:AZN) Influenced FTSE 100 Today Amid Broader Updates
July 04, 2025 09:00 AM AEST| By Team Kalkine MediaHighlights,FTSE 100 today opened lower amid tariff-related updates and cross-border developments,AstraZeneca received European Union approval for a cancer treatment,Market sentiment across major European indices showed coordinated softness,The,FTSE 1...
FTSE AIM UK 50 Index: Why Abingdon Health (LSE:ABDX) Shares Moved Following Recent Updates?
July 03, 2025 07:26 PM AEST| By Team Kalkine MediaHighlights:,Abingdon Health shares experienced movement.,The company operates within the medical diagnostics sector.,The company is listed on the FTSE AIM UK 50 Index.,Abingdon Health (LSE:ABDX), part of the,FTSE AIM UK 50 Index,, operates within the...
Convatec Group’s Performance in the FTSE 100 Healthcare Segment
June 28, 2025 02:20 AM AEST| By Team Kalkine MediaHighlights,Convatec Group operates within the healthcare sector and is listed on the FTSE 100,The company's performance spans wound care, ostomy care, continence, and infusion devices,Continued momentum reported across business segments,Convatec Grou...
AstraZeneca (LSE:AZN) Gains FDA Nod for Datroway in Lung Cancer, Enhancing FTSE 100 Oncology Focus
June 27, 2025 02:17 AM AEST| By Team Kalkine MediaHighlights,AstraZeneca secures FDA accelerated approval for Datroway in treating advanced EGFR-mutated non-small cell lung cancer,The company's share price remains steady despite recent positive regulatory developments,Ongoing advancements in oncolog...
Smith & Nephew’s Role in the FTSE 100 Healthcare Segment
June 25, 2025 11:41 PM AEST| By Team Kalkine MediaHighlights,Smith & Nephew plc (LON:SN) operates within the healthcare sector under the FTSE 100,The company is known for orthopaedics, sports medicine, and wound management,Its operations span globally, with focus on innovation across surgical techno...
Tissue Regenix (LON:TRX) Strengthens Presence in FTSE AIM 100 Index
June 25, 2025 06:31 PM AEST| By Team Kalkine MediaHighlights,Tissue Regenix Group PLC (LON:TRX) operates within the FTSE AIM 100 Index,Expanded distribution channels and tissue processing capacity in regenerative medical devices,San Antonio facility acquisition aligns with future scalability objecti...
Scancell Holdings (LON:SCLP) Advances Immunotherapy Trials in FTSE AIM
June 25, 2025 05:32 PM AEST| By Team Kalkine MediaHighlights,Scancell Holdings PLC (LON:SCLP) is listed on the FTSE AIM UK 50 INDEX, operating in the biotechnology sector,The company is conducting a phase II trial for its iSCIB1+ cancer immunotherapy for advanced melanoma,Plans to spin off its GlyMa...
Datroway Boosts AstraZeneca’s Role in Lung Cancer Therapy | FTSE 100 Focus
June 25, 2025 12:30 AM AEST| By Team Kalkine MediaHighlights,AstraZeneca PLC (LON:AZN), listed on the,FTSE 100,, gains FDA accelerated approval for Datroway in advanced lung cancer.,Datroway, an antibody-drug conjugate developed with Daiichi Sankyo, shows promise in treating non-small cell lung canc...
Polarean Imaging (LON:POLX) Expands US Reach with Strategic Agreement
June 24, 2025 10:30 PM AEST| By Team Kalkine MediaHighlights,Polarean Imaging (LON:POLX) enters a commercial partnership with Ascend Imaging to enhance distribution in key US regions,The agreement supports the of Polarean’s xenon-based MRI technology without expanding internal headcount,Market respo...
Monument Therapeutics Advances CIAS Treatment in FTSE AIM Index
June 24, 2025 08:30 PM AEST| By Team Kalkine MediaHighlights,Monument Therapeutics progresses in treating cognitive impairment in schizophrenia.,Cambridge Cognition (LON:COG) supports development through digital assessment tools.,Both firms are listed under the FTSE AIM UK 50 Index and FTSE AIM 100...
GlaxoSmithKline Maintains Pipeline Strength and Dividend Appeal | FTSE 100
June 24, 2025 08:29 PM AEST| By Team Kalkine MediaHighlights,GlaxoSmithKline plc (LON:GSK) operates in the pharmaceuticals sector under the FTSE 100 and FTSE 350 indices,The company continues developing treatments across respiratory, HIV, and oncology portfolios,GSK is featured in the FTSE Dividend...
Polarean Imaging (LON:POLX) Expands Reach in US Market
June 24, 2025 05:31 PM AEST| By Team Kalkine MediaHighlights,Polarean Imaging PLC (LON:POLX) operates within the medical technology sector with a focus on advanced lung imaging.,The company has entered a non-exclusive distribution agreement with Ascend Imaging in the US.,The collaboration aims to en...
GSK Seeks EMA Nod for Linerixibat After Positive Phase III Data | FTSE 100 Update
June 23, 2025 08:51 PM AEST| By Team Kalkine MediaHighlights,GSK submits application to the European Medicines Agency for linerixibat in treating pruritus in PBC,EMA decision follows earlier FDA acceptance for the same treatment,Phase III results presented at the EASL Congress showed consistent clin...
Fusion Antibodies (LON:FAB) Sees Share Price Movement Amid Low Trading Activity on FTSE AIM
June 20, 2025 06:47 PM AEST| By Team Kalkine MediaHighlights,Fusion Antibodies (LON:FAB) recorded a drop in share price during mid-week trading,Trading volume saw a significant decline compared to typical activity,Insider share purchase activity recorded in recent weeks,Fusion Antibodies (LON:FAB),...
4basebio PLC (LON:4BB) Sees Upward Movement on Low Volume – Life Sciences Sector Update
June 19, 2025 06:05 PM AEST| By Team Kalkine MediaHighlights,4basebio PLC (LON:4BB) experiences an uptick in trading with limited volume activity,Company remains focused on synthetic DNA and gene therapy delivery innovations,Insider acquisition adds visibility to internal shareholding activity,4base...
RUA Life Sciences (LON:RUA) Sees Trading Activity Boost on FTSE AIM UK 50 Index
June 19, 2025 05:50 PM AEST| By Team Kalkine MediaHighlights,Shares of RUA Life Sciences (LON:RUA) moved higher during Wednesday's trading session,Trading volume rose compared to its typical daily average,The company operates in the medical technology sector with a focus on implantable polymers,RUA...
FTSE 100 Inches Up Amid Cooling Inflation as Pharma Stocks Decline
June 19, 2025 03:30 AM AEST| By Team Kalkine MediaHighlights,FTSE 100 shows minor gains following a decline in inflation indicators for May,Pharmaceutical shares experience downward movement following tariff remarks from the U.S.,GSK (LON:GSK) and AstraZeneca (LON:AZN) among key stocks trading lower...
Astoriom (LON:ASTR) Taps New CFO to Drive Global Growth in Biorepository and Stability Services
June 17, 2025 06:50 PM AEST| By Team Kalkine MediaHighlights,Brittany Jackson appointed as CFO to lead financial and strategic initiatives,Brings leadership experience across biotech, education, and professional services sectors,Focus on operational maturity, innovation, and global market expansion,...
AI on the Rise: A Look at Top AI Companies and Their Stocks